Evidence-Based Medicine Guidelines
Five-alpha-reductase inhibitors for prostate cancer prevention
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Five-alpha-reductase Inhibitors for Prostate Cancer Prevention." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456901/all/Five_alpha_reductase_inhibitors_for_prostate_cancer_prevention.
Five-alpha-reductase inhibitors for prostate cancer prevention. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456901/all/Five_alpha_reductase_inhibitors_for_prostate_cancer_prevention. Accessed September 11, 2024.
Five-alpha-reductase inhibitors for prostate cancer prevention. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456901/all/Five_alpha_reductase_inhibitors_for_prostate_cancer_prevention
Five-alpha-reductase Inhibitors for Prostate Cancer Prevention [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456901/all/Five_alpha_reductase_inhibitors_for_prostate_cancer_prevention.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Five-alpha-reductase inhibitors for prostate cancer prevention
ID - 456901
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456901/all/Five_alpha_reductase_inhibitors_for_prostate_cancer_prevention
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
